Real-Life Effectiveness of Infliximab in the Treatment of Rheumatoid Arthritis: The Canadian Experience

被引：0
|
作者：
Choquette, Denis [1 ]
Bensen, William [2 ]
Khalil, Hayssam [3 ]
Sampalis, John [4 ]
机构：
[1] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] Schering Plough Canada, Montreal, PQ, Canada
[4] Univ Montreal, Westmount, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页码：1283 / 1283
页数：1
相关论文
共 50 条
  • [11] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-LIFE EXPERIENCE
    Sarmiento-Monroy, J. C.
    Rodriguez-Lopez, M.
    Molano-Gonzalez, N.
    Rojas-Villarraga, A.
    Mantilla, R. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 725 - 725
  • [12] Low Rates of Infliximab Dose Titration and Discontinuation Are Observed in Rheumatoid Arthritis (RA) Patients in a Real-life Canadian Cohort
    Bensen, Bill
    Faraawi, Rafat
    Khalil, Hayssam
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1154 - 1154
  • [13] Real-World Effectiveness of Infliximab in the Treatment of Psoriatic Arthritis over 12 Months: The Canadian Experience
    Rahman, Proton
    Khraishi, Majed
    Bensen, William
    Sholter, Dalton
    Hanna, Brian
    Watts, Craig
    Rampakakis, Emmanouil
    Sampalis, John
    Shawi, May
    Otawa, Susan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1010 - 1011
  • [14] Real-World Effectiveness Of Infliximab In The Treatment Of Psoriatic Arthritis Over 12 Months: The Canadian Experience
    Rahman, Proton
    Khraishi, Majed M.
    Bensen, William
    Kelsall, John T.
    Hanna, Brian D.
    Watts, Craig
    Rampakakis, Emmanouil
    Sampalis, John S.
    Shawi, May
    Otawa, Susan M.
    Lehman, Allen J.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S660 - S660
  • [15] LONG-TERM COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE CLINICAL PRACTICE
    Cardenas, M.
    de la Fuente, S.
    Font-Ugalde, P.
    Castro-Villegas, M. C.
    Romero-Gomez, M.
    Ruiz-Vilchez, D.
    Calvo-Gutierrez, J.
    Ortega-Castro, R.
    Escudero-Contreras, A.
    Casado, M. A.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 703 - 703
  • [16] Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience
    Jois, R. N.
    Masilling, A.
    Somerville, M.
    Gaffney, K.
    Scott, D. G. I.
    RHEUMATOLOGY, 2007, 46 (06) : 980 - 982
  • [17] EFFECTIVENESS AND SAFETY OF BIOSIMILAR INFLIXIMAB (CT-P13) IN A REAL-LIFE SETTING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Codreanu, C.
    Sirova, K.
    Jarosova, K.
    Batalov, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 489 - 489
  • [18] Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis
    Codreanu, Catalin
    Sirova, Klara
    Jarosova, Katerina
    Batalov, Anastas
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (10) : 1763 - 1769
  • [19] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [20] RETROSPECTIVE COHORT STUDY OF EARLY REAL-LIFE EXPERIENCE WITH BARICITINIB IN RHEUMATOID ARTHRITIS
    Tan, Jeanette
    Davies, Sonja
    Linton, Stuart
    RHEUMATOLOGY, 2019, 58 : 183 - 183
12345